Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
vivjoa
Synonyms :
Oteseconazole
Class :
Azole antifungal
Dosage Forms & StrengthsÂ
150mgÂ
Only Oteseconazole dosage regimen:
Day 1:600mg orally in a single dose
Day 2:450mg orally in a single dose
Day 14:150mg orally every week for 11 weeks
Oteseconazole and fluconazole dosage regimen:
Day 1,4 and 7: Fluconazole-150mg orally in a single dose
Day 14 to 20: Oteseconazole-150mg orally every day for seven days
Beginning on day 28: Oteseconazole-150mg orally every week for 11 weeks
may increase the serum concentration
may enhance the serum concentration of BRCP/ABCG2 inhibitors
may enhance the serum concentration of BRCP/ABCG2 inhibitors
may enhance the serum concentration of BRCP/ABCG2 inhibitors
may enhance the serum concentration of BRCP/ABCG2 inhibitors
may enhance the serum concentration of BRCP/ABCG2 inhibitors
may enhance the serum concentration of BRCP/ABCG2 inhibitors
may enhance the serum concentration of BRCP/ABCG2 inhibitors
Frequency defined:Â Â
1-10%Â
NauseaÂ
Hot flushÂ
MenorrhagiaÂ
Vulvovaginal irritationÂ
HeadacheÂ
DyspepsiaÂ
DysuriaÂ
MetrorrhagiaÂ
Elevated serum creatinine phosphokinase≥10X ULNÂ
<1%Â
Allergic dermatitisÂ
Pregnancy consideration:Â Â
US FDA pregnancy category: Not assignedÂ
Lactation: In lactating women, the usage is contraindicatedÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Patient information leafletÂ
Generic Name: OteseconazoleÂ
Pronounced: (oh-TES-e-KON-a-zole)Â
Why do we use Oteseconazole?Â
It is used to treat vulvovaginal candidiasis, which is recurrent in females with less reproductive potentialÂ